Document Security Systems (DSS)

$0.61 +0.01 (1.53%)
Market Cap 6.12M
Revenue (ttm) 20.76M
Net Income (ttm) -23.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -115.27%
Debt to Equity Ratio 2.97
Volume 57,400
Avg Vol 1,824,968
Day's Range N/A - N/A
Shares Out 10.04M
Stochastic %K 79%
Beta 0.95
Analysts Strong Sell
Price Target $3.00

Company Profile

DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advanceme...

Industry: Packaging & Containers
Sector: Consumer Cyclical
Phone: 585 325 3610
Address:
275 Wiregrass Parkway, West Henrietta, United States
johannn
johannn Jul. 1 at 6:40 PM
$IBO $DSS $AEI $HWH Well, well, it’s already been over a year and still no strategic merger https://www.impactbiomedinc.com/dr-ashleys-limited-and-impact-biomedical-inc-announce-strategic-merger/ And on April 03, 2026 at 13:52 ET another worthless press release came from these scammers, in which we are lied to about a new date again, namely .... Separately, Impact Biomedical continues with strategic plans to merge with Dr. Ashley’s Ltd. (here), projected to be completed by July 1, 2026. https://www.globenewswire.com/news-release/2026/04/03/3268111/0/en/impact-biomedical-inc-reports-going-concern-audit-opinion-in-2025-10-k-filing-while-continuing-strategic-merger-plans.html It appears that the merger involving the two fraudulent companies IBO and Dr Ashley, which is now called Zoar Inc. after a name change, will not go ahead; that was, of course, to be expected.🕵️🕵️🥷🥷
0 · Reply
JoaoCarvalho
JoaoCarvalho Jul. 1 at 9:22 AM
$DSS When moon?
0 · Reply
JohnQpub
JohnQpub Jun. 30 at 7:23 PM
$DSS 16% short nibble nibble
1 · Reply
johannn
johannn Jun. 25 at 8:33 PM
$DSS $IBO $AEI $HWH As was to be expected, since the real market is not interested in these scam stocks, they just continue shuffling junk around among themselves to let the dilution continue. https://www.sec.gov/ix?doc=/Archives/edgar/data/0000771999/000149315226030115/form8-k.htm
0 · Reply
TempleofBoom
TempleofBoom Jun. 18 at 2:04 PM
$DSS 0.58
0 · Reply
JoaoCarvalho
JoaoCarvalho Jun. 13 at 11:11 PM
$DSS Can we go to 0.85 next week?
0 · Reply
jucebot
jucebot Jun. 12 at 5:53 PM
Jovanotti loaded up a long in $DSS @ $0.63 $MAAS $UBXG
0 · Reply
jucebot
jucebot Jun. 12 at 3:25 PM
Jovanotti just scaled into a long on $POET @ $12.83 $AXTX $CIIT $CRWU $DSS $RKDA
0 · Reply
jucebot
jucebot Jun. 12 at 3:25 PM
Jovanotti started a long in $DSS @ $0.63 $AXTX $CIIT $CRWU $RKDA
0 · Reply
JoaoCarvalho
JoaoCarvalho Jun. 12 at 2:02 AM
$DSS 1 + 1 = 0,61 Explain to me...
0 · Reply
Latest News on DSS
DSS, Inc. Withdraws Registration Statement

Jun 9, 2026, 10:15 AM EDT - 25 days ago

DSS, Inc. Withdraws Registration Statement

DSS, Inc. Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 7 weeks ago

DSS, Inc. Quarterly report: Q1 2026

DSS reports ‘going concern’ audit opinion in 2025 10-K filing

2026-05-08T22:49:06.000Z - 2 months ago

DSS reports ‘going concern’ audit opinion in 2025 10-K filing

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

May 8, 2026, 5:00 PM EDT - 2 months ago

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

DSS, Inc. Registration statement: Registration filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

DSS, Inc. Registration statement: Registration filing

DSS, Inc. Registration statement: Registration filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

DSS, Inc. Registration statement: Registration filing

DSS, Inc. Annual report: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 3 months ago

DSS, Inc. Annual report: Q4 2025

DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering

Feb 5, 2026, 9:45 AM EST - 5 months ago

DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering

DSS prices 900,000 shares at $1.00 in underwritten public offering

2026-02-04T13:40:35.000Z - 5 months ago

DSS prices 900,000 shares at $1.00 in underwritten public offering

DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering

Feb 4, 2026, 8:35 AM EST - 5 months ago

DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering

DSS, Inc. Announces Launch of Proposed Public Offering

Feb 3, 2026, 8:17 PM EST - 5 months ago

DSS, Inc. Announces Launch of Proposed Public Offering

DSS, Inc. Quarterly report: Q3 2025

Nov 14, 2025, 4:00 PM EST - 8 months ago

DSS, Inc. Quarterly report: Q3 2025

DSS, Inc. Proxy statement: Proxy Filing

Oct 21, 2025, 8:00 AM EDT - 9 months ago

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. Proxy statement: Proxy Filing

Oct 20, 2025, 8:00 AM EDT - 9 months ago

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

DSS, Inc. Quarterly report: Q2 2025

DSS’ Impact BioMedical announces strategic merger with Dr. Ashley’s

2025-06-24T12:35:23.000Z - 1 year ago

DSS’ Impact BioMedical announces strategic merger with Dr. Ashley’s

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

May 22, 2025, 8:31 AM EDT - 1 year ago

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

DSS, Inc. Quarterly report: Q1 2025

May 15, 2025, 4:00 PM EDT - 1 year ago

DSS, Inc. Quarterly report: Q1 2025

DSS, Inc. Annual report: Q4 2024

Mar 31, 2025, 8:00 AM EDT - 1 year ago

DSS, Inc. Annual report: Q4 2024

DSS announces sale of Celios to Impact BioMedical

2025-02-26T13:41:33.000Z - 1 year ago

DSS announces sale of Celios to Impact BioMedical

IBO

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

Feb 26, 2025, 8:30 AM EST - 1 year ago

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

DSS interim CEO says immediate focus is to ‘optimize operational efficiencies’

2025-02-03T14:00:40.000Z - 1 year ago

DSS interim CEO says immediate focus is to ‘optimize operational efficiencies’

DSS, Inc. Issues Letter to Shareholders

Feb 3, 2025, 8:50 AM EST - 1 year ago

DSS, Inc. Issues Letter to Shareholders

LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals

Jan 15, 2025, 9:35 AM EST - 1 year ago

LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals

DSS, Inc. Quarterly report: Q3 2024

Nov 14, 2024, 12:30 PM EST - 1 year ago

DSS, Inc. Quarterly report: Q3 2024

DSS, Inc. Registration statement: Registration Filing

Oct 31, 2024, 8:00 AM EDT - 1 year ago

DSS, Inc. Registration statement: Registration Filing

DSS, Inc. Proxy statement: Proxy Filing

Oct 22, 2024, 8:00 AM EDT - 1 year ago

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

Sep 16, 2024, 4:26 PM EDT - 1 year ago

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

AmericaFirst Funds Trust Announces Changes to Board of Trustees

Sep 10, 2024, 9:00 AM EDT - 1 year ago

AmericaFirst Funds Trust Announces Changes to Board of Trustees

DSS, Inc. Registration statement: Registration Filing

Sep 6, 2024, 8:00 AM EDT - 1 year ago

DSS, Inc. Registration statement: Registration Filing

DSS, Inc. Names Jason Grady as Interim Chief Executive Officer

Aug 26, 2024, 4:08 PM EDT - 2 years ago

DSS, Inc. Names Jason Grady as Interim Chief Executive Officer

DSS, Inc. Quarterly report: Q2 2024

Aug 12, 2024, 6:00 PM EDT - 2 years ago

DSS, Inc. Quarterly report: Q2 2024

DSS, Inc. Quarterly report: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

DSS, Inc. Quarterly report: Q1 2024

DSS, Inc. Earnings release: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

DSS, Inc. Earnings release: Q1 2024

DSS, Inc. Earnings release: Q4 2023

Mar 27, 2024, 8:00 AM EDT - 2 years ago

DSS, Inc. Earnings release: Q4 2023

DSS, Inc. Annual report: Q4 2023

Mar 27, 2024, 8:00 AM EDT - 2 years ago

DSS, Inc. Annual report: Q4 2023

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

Jan 30, 2024, 8:05 AM EST - 2 years ago

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

Jan 4, 2024, 8:15 AM EST - 2 years ago

DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

Dec 22, 2023, 4:30 PM EST - 2 years ago

DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

Nov 28, 2023, 8:10 AM EST - 2 years ago

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

DSS, Inc. Quarterly report: Q3 2023

Nov 14, 2023, 12:00 AM EST - 2 years ago

DSS, Inc. Quarterly report: Q3 2023

DSS, Inc. Earnings release: Q3 2023

Nov 14, 2023, 12:00 AM EST - 2 years ago

DSS, Inc. Earnings release: Q3 2023

DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder's Common Stock

Nov 8, 2023, 8:31 AM EST - 2 years ago

DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder's Common Stock

DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule

Oct 26, 2023, 5:25 PM EDT - 2 years ago

DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule

DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical

Oct 23, 2023, 8:25 AM EDT - 2 years ago

DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical

DSS Inc. Issues Letter to Shareholders

Oct 12, 2023, 8:25 AM EDT - 2 years ago

DSS Inc. Issues Letter to Shareholders

DSS, Inc. Proxy statement: Proxy Filing

Sep 12, 2023, 8:00 AM EDT - 3 years ago

DSS, Inc. Proxy statement: Proxy Filing

DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary

Sep 6, 2023, 8:40 AM EDT - 3 years ago

DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary

DSS, Inc. Quarterly report: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Quarterly report: Q2 2023

DSS, Inc. Earnings release: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Earnings release: Q2 2023

DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.

Jul 31, 2023, 8:15 AM EDT - 3 years ago

DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.

DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.

Jul 5, 2023, 8:15 AM EDT - 3 years ago

DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.

DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.

Jun 30, 2023, 9:34 AM EDT - 3 years ago

DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.

DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend

Jun 26, 2023, 8:20 AM EDT - 3 years ago

DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend

DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

May 16, 2023, 9:00 AM EDT - 3 years ago

DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

DSS, Inc. Quarterly report: Q1 2023

May 16, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Quarterly report: Q1 2023

DSS, Inc. Earnings release: Q1 2023

May 16, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Earnings release: Q1 2023

DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders

May 1, 2023, 8:25 AM EDT - 3 years ago

DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders

DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders

Apr 19, 2023, 9:08 AM EDT - 3 years ago

DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders

DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM

Apr 17, 2023, 10:00 AM EDT - 3 years ago

DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM

DSS, Inc. Annual report: Q4 2022

Mar 31, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Annual report: Q4 2022

DSS, Inc. Earnings release: Q4 2022

Mar 31, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Earnings release: Q4 2022

DSS Announces Letter to Shareholders

Mar 2, 2023, 8:30 AM EST - 3 years ago

DSS Announces Letter to Shareholders

DSS, Inc. Quarterly report: Q3 2022

Nov 14, 2022, 7:00 AM EST - 3 years ago

DSS, Inc. Quarterly report: Q3 2022

DSS, Inc. Earnings release: Q3 2022

Nov 14, 2022, 7:00 AM EST - 3 years ago

DSS, Inc. Earnings release: Q3 2022

DSS, Inc. Proxy statement: Proxy Filing

Oct 21, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. Quarterly report: Q2 2022

Sep 14, 2022, 7:00 AM EDT - 4 years ago

DSS, Inc. Quarterly report: Q2 2022

DSS, Inc. Earnings release: Q2 2022

Sep 14, 2022, 7:00 AM EDT - 4 years ago

DSS, Inc. Earnings release: Q2 2022

DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing

Aug 30, 2022, 4:45 PM EDT - 4 years ago

DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing

DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs

Jul 21, 2022, 5:00 PM EDT - 4 years ago

DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs

DSS Strengthens and Expands Board with Appointment of Two Independent Directors

Jul 13, 2022, 8:00 AM EDT - 4 years ago

DSS Strengthens and Expands Board with Appointment of Two Independent Directors

Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

Jun 28, 2022, 8:00 AM EDT - 4 years ago

Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

DSS's Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

Jun 7, 2022, 7:00 AM EDT - 4 years ago

DSS's Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

DSS, Inc. Quarterly report: Q1 2022

May 16, 2022, 8:30 AM EDT - 4 years ago

DSS, Inc. Quarterly report: Q1 2022

DSS, Inc. Earnings release: Q1 2022

May 16, 2022, 8:30 AM EDT - 4 years ago

DSS, Inc. Earnings release: Q1 2022

DSS, Inc. Proxy statement: Proxy Filing

May 9, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

May 6, 2022, 8:30 AM EDT - 4 years ago

DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

DSS, Inc. Proxy statement: Proxy Filing

Apr 26, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. Proxy statement: Proxy Filing

Apr 15, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. Proxy statement: Proxy Filing

Apr 4, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. Annual report: Q4 2021

Mar 31, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Annual report: Q4 2021

CORRECTION - DSS Announces Letter to Shareholders

Feb 28, 2022, 5:15 PM EST - 4 years ago

CORRECTION - DSS Announces Letter to Shareholders

DSS to Present at Aegis Virtual Conference

Feb 22, 2022, 5:00 PM EST - 4 years ago

DSS to Present at Aegis Virtual Conference

DSS Receives $17 Million Investment from Alset EHome International

Jan 25, 2022, 4:30 PM EST - 4 years ago

DSS Receives $17 Million Investment from Alset EHome International

DSS, Inc. Proxy statement: Proxy Filing

Jan 24, 2022, 7:00 AM EST - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing

DSS Acquires 25.1% of Alset International Limited

Jan 19, 2022, 12:13 PM EST - 4 years ago

DSS Acquires 25.1% of Alset International Limited

DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building

Jan 12, 2022, 8:30 AM EST - 4 years ago

DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building

Impact BioMedical Announces New Bioplastics Test Results

Jan 11, 2022, 10:00 AM EST - 4 years ago

Impact BioMedical Announces New Bioplastics Test Results

DSS Provides Update on Expansion of Premier Packaging Subsidiary

Dec 22, 2021, 7:30 AM EST - 4 years ago

DSS Provides Update on Expansion of Premier Packaging Subsidiary

DSS's American Pacific Bancorp Approaches $20M in New Loans Issued

Dec 20, 2021, 10:10 AM EST - 4 years ago

DSS's American Pacific Bancorp Approaches $20M in New Loans Issued

DSS Opens Sacramento Office for its DSS Wealth Management and DSS AmericaFirst Quantitative Funds

Dec 15, 2021, 7:30 AM EST - 4 years ago

DSS Opens Sacramento Office for its DSS Wealth Management and DSS AmericaFirst Quantitative Funds

DSS to Present at the Emerging Growth Conference on December 8

Dec 7, 2021, 7:30 AM EST - 4 years ago

DSS to Present at the Emerging Growth Conference on December 8

DSS Enters Quantitative Investment Fund Arena

Nov 30, 2021, 7:30 AM EST - 4 years ago

DSS Enters Quantitative Investment Fund Arena

DSS Expands American Medical REIT with Acquisition of Three Established Acute Care Hospitals in Texas and Pennsylvania

Nov 4, 2021, 9:00 AM EDT - 5 years ago

DSS Expands American Medical REIT with Acquisition of Three Established Acute Care Hospitals in Texas and Pennsylvania

DSS, Inc. Proxy statement: Proxy Filing

Oct 1, 2021, 8:00 AM EDT - 5 years ago

DSS, Inc. Proxy statement: Proxy Filing

Document Security Systems, Inc. to Change Its Name to DSS, Inc. to Reflect Sweeping Organizational Changes and Ongoing Business Expansions

Sep 20, 2021, 7:30 AM EDT - 5 years ago

Document Security Systems, Inc. to Change Its Name to DSS, Inc. to Reflect Sweeping Organizational Changes and Ongoing Business Expansions

Alset EHome International Inc.'s American Pacific Bancorp Subsidiary Receives USD $40 Million Investment from Document Security Systems, Inc.

Sep 9, 2021, 7:00 AM EDT - 5 years ago

Alset EHome International Inc.'s American Pacific Bancorp Subsidiary Receives USD $40 Million Investment from Document Security Systems, Inc.

AEI

johannn
johannn Jul. 1 at 6:40 PM
$IBO $DSS $AEI $HWH Well, well, it’s already been over a year and still no strategic merger https://www.impactbiomedinc.com/dr-ashleys-limited-and-impact-biomedical-inc-announce-strategic-merger/ And on April 03, 2026 at 13:52 ET another worthless press release came from these scammers, in which we are lied to about a new date again, namely .... Separately, Impact Biomedical continues with strategic plans to merge with Dr. Ashley’s Ltd. (here), projected to be completed by July 1, 2026. https://www.globenewswire.com/news-release/2026/04/03/3268111/0/en/impact-biomedical-inc-reports-going-concern-audit-opinion-in-2025-10-k-filing-while-continuing-strategic-merger-plans.html It appears that the merger involving the two fraudulent companies IBO and Dr Ashley, which is now called Zoar Inc. after a name change, will not go ahead; that was, of course, to be expected.🕵️🕵️🥷🥷
0 · Reply
JoaoCarvalho
JoaoCarvalho Jul. 1 at 9:22 AM
$DSS When moon?
0 · Reply
JohnQpub
JohnQpub Jun. 30 at 7:23 PM
$DSS 16% short nibble nibble
1 · Reply
johannn
johannn Jun. 25 at 8:33 PM
$DSS $IBO $AEI $HWH As was to be expected, since the real market is not interested in these scam stocks, they just continue shuffling junk around among themselves to let the dilution continue. https://www.sec.gov/ix?doc=/Archives/edgar/data/0000771999/000149315226030115/form8-k.htm
0 · Reply
TempleofBoom
TempleofBoom Jun. 18 at 2:04 PM
$DSS 0.58
0 · Reply
JoaoCarvalho
JoaoCarvalho Jun. 13 at 11:11 PM
$DSS Can we go to 0.85 next week?
0 · Reply
jucebot
jucebot Jun. 12 at 5:53 PM
Jovanotti loaded up a long in $DSS @ $0.63 $MAAS $UBXG
0 · Reply
jucebot
jucebot Jun. 12 at 3:25 PM
Jovanotti just scaled into a long on $POET @ $12.83 $AXTX $CIIT $CRWU $DSS $RKDA
0 · Reply
jucebot
jucebot Jun. 12 at 3:25 PM
Jovanotti started a long in $DSS @ $0.63 $AXTX $CIIT $CRWU $RKDA
0 · Reply
JoaoCarvalho
JoaoCarvalho Jun. 12 at 2:02 AM
$DSS 1 + 1 = 0,61 Explain to me...
0 · Reply
Unsu
Unsu Jun. 12 at 1:31 AM
$DSS
0 · Reply
kseiba
kseiba Jun. 11 at 7:00 PM
$DSS this is dead
0 · Reply
Kingshard
Kingshard Jun. 11 at 5:04 PM
$DSS they wont let it pass .80 so if you're not flipping from .57 to .80 range it's a waste for now
0 · Reply
kseiba
kseiba Jun. 11 at 4:46 PM
$DSS i thought this would go up for sure, damn!
0 · Reply
Jfstricker
Jfstricker Jun. 11 at 3:56 PM
$DSS somebody searching for stop losses?
0 · Reply
GTMStox
GTMStox Jun. 11 at 2:21 PM
$DSS Ya gotta love 6 cent spreads on 65 cents stock
0 · Reply
Stonkman88
Stonkman88 Jun. 11 at 1:48 PM
$DSS let it run
0 · Reply
bigone123
bigone123 Jun. 11 at 12:47 PM
$DSS this is bad
0 · Reply
BigBoyTroy
BigBoyTroy Jun. 11 at 12:10 PM
$DSS I'm liking this set up bought the dip. Free discord link in My stocktwits profile my bullish peeps 🐂
0 · Reply
ISmokeCigs
ISmokeCigs Jun. 11 at 11:49 AM
$DSS hmmmmm
0 · Reply
Stonkman88
Stonkman88 Jun. 11 at 11:25 AM
$DSS could be next like $GLXG $CCHH $EDHL
0 · Reply
DidnotSeeThat
DidnotSeeThat Jun. 11 at 11:17 AM
$DSS here we go🍻 GL
0 · Reply